Avoiding plastic bottles, cutting boards and food containers may reduce exposure, but plastics have become so widespread that they are increasingly difficult to avoid.
New peer-reviewed research published in Frontiers in Microbiology reports the first human in-vivo proof-of-concept evidence of an administered technology intentionally designed to physically capture microplastics.
The study evaluated Qi601®, a proprietary, non-living postbiotic developed by Quorum Innovations to bind micro- and nanoplastics within the gastrointestinal tract before they can interact with intestinal cells.